Ad­vo­cates call on Vi­iV to low­er price of long-act­ing HIV in­jectable

More than 70 ad­vo­cates — rang­ing from ac­tors to CEOs — signed a let­ter to Vi­iV chief ex­ec­u­tive Deb­o­rah Wa­ter­house on Tues­day re­quest­ing a low­er price for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER